Viewing Study NCT06207656


Ignite Creation Date: 2025-12-24 @ 11:30 PM
Ignite Modification Date: 2025-12-25 @ 9:18 PM
Study NCT ID: NCT06207656
Status: RECRUITING
Last Update Posted: 2024-10-21
First Post: 2023-12-27
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Study to Evaluate the Efficacy and Safety of Cetuximab in Combination with Encorafenib Plus Binimetinib As Induction Treatment in BRAF V600E Mutated MSS Initially Resectable or Potentially Resectable Advanced Colorectal Cancer
Sponsor: Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module